Priyanka R. Alluri

Priyanka R. Alluri

Auto-generated profile, based on publicly available information

Priyanka R. Alluri

Functional Neurology Research Group, Cognitive Behavioral Neurology Unit, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2020 in Psychosomatics
Verified
Journal Article
Closed access
JRJessica Ranford
Jessica Ranford
JMJulie MacLean
Julie MacLean
PAPriyanka R. Alluri
Priyanka R. Alluri
OCOlivia Comeau
Olivia Comeau
EGEllen Godena
Ellen Godena
DPDavid L. Perez
David L. Perez

1 June 2020 in Cognitive and Behavioral Neurology
Verified
Journal Article
Closed access
PAPriyanka R. Alluri
Priyanka R. Alluri
JSJuliet Solit
Juliet Solit
CLCatherine L. Leveroni
Catherine L. Leveroni
KGKatherine Goldberg
Katherine Goldberg
JVJulia V. Vehar
Julia V. Vehar
DPDavid L. Perez
David L. Perez
Functional neurological (conversion) disorder (FND) is a neuropsychiatric condition characterized by sensorimotor symptoms exhibiting features incompatible with other neurologic diseases. Individuals with motor FND (mFND) typically present with limb weakness, nonepileptic seizures, and/or abnormal movements. However, this population also frequently reports clouded thinking, inattention, and memory difficulties. Cognitive complaints in individuals with mFND are important to evaluate as they may negatively impact quality of life and impede treatment engagement. We provide a narrative review of the neuropsychological testing literature detailing neurocognitive profiles of individuals with mFND. We also present three illustrative clinical cases at the intersection of mFND and cognitive concerns. Several studies and our case examples highlight that generally normal cognitive performance can be observed concurrently with subjective cognitive complaints in some individuals with mFND; this mismatch may be a possible “rule-in” sign of functional cognitive symptoms. Other studies have reported impairments in attention, memory, language, visuospatial, and executive functioning in individuals with mFND. These impairments could be related to medical-psychiatric comorbidities, psychotropic medication side effects, and intrinsic disease mechanisms. When evaluating individuals with mFND and their cognitive complaints, clinicians can use performance validity test and psychopathology findings to help them interpret the neuropsychological test results. Perceptual mismatches between intact objective cognitive performance and subjective cognitive complaints may reflect a negative attentional bias for cognitive abilities that can be targeted with cognitive retraining and cognitive behavioral therapy. Neuropsychological evaluations may provide a useful adjunctive tool clinicians can use to help assess individuals with mFND and cognitive concerns.